- Country: Italy
- Summary: Acp3588ag_Negotiable Procedure Called by Ast_An for the Supply of the Monoclonal Antibody Nirvesimab Medicinal Product Called Beyfortus for the Need of Ssr Entities - Given Information
- ITT Ref No: 111570651
- Deadline: 25 Jan 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 756568-2024
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- ACP3588AG_NEGOTIATED PROCEDURE CALLED BY AST_AN, AS AN INSTITUTION AUTHORIZED BY THE AGGREGATOR FOR THE SUPPLY OF THE MONOCLONAL ANTIBODY NIRVESIMAB MEDICINAL PRODUCT CALLED BEYFORTUS FOR NECESSITY OF SSR ENTITIES - TAKEN BY DATTO
ACP3588AG_NEGOTIED PROCEDURE CALLED BY AST_AN FOR SUPPLY OF THE ANTIBODY - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAcp3588ag_Negotiable Procedure Called by Ast_An for the Supply of the Monoclonal Antibody Nirvesimab Medicinal Product Called Beyfortus for the Need of Ssr Entities - Given Information - Italy Tender
The MARCHE UNIVERSITY HOSPITAL, a Government sector organization in Italy, has announced a new tender for Acp3588ag_Negotiable Procedure Called by Ast_An for the Supply of the Monoclonal Antibody Nirvesimab Medicinal Product Called Beyfortus for the Need of Ssr Entities - Given Information. This tender is published on ItalyTenders under ITT Ref No: 111570651 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-01-25.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
